United States · 
Who invested in OnCusp Therapeutics?
OnCusp Therapeutics's investors include HSG, OrbiMed, Blackbird Ventures and Catalio Capital Management.
United States · Series A startup
Who invested in OnCusp Therapeutics
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $100MJan 2024
- Investors
- 4
The rounds
- Jan 2024
Founders and team
From OnCusp Therapeutics's own website: 4 on the team.
- Daphne FarringtonVice President, Clinical Development
- Priya MarreddyVice President of Clinical Operations
- Chau KhuongInterim Chair of the Board, Independent Board Member
- Michael T. AndrioleIndependent Board Member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about OnCusp Therapeutics
How much has OnCusp Therapeutics raised?
OnCusp Therapeutics has raised $100M across 1 round since 2024.
When did OnCusp Therapeutics last raise?
OnCusp Therapeutics's most recent round was a Series A of $100M in Jan 2024.
What was OnCusp Therapeutics's biggest round?
Its most recent round, $100M in Jan 2024, is also its largest on record.
Who backed OnCusp Therapeutics first?
OnCusp Therapeutics's first round on record, in Jan 2024, was backed by HSG, OrbiMed and Blackbird Ventures and 1 others.
What stage is OnCusp Therapeutics at?
OnCusp Therapeutics's latest named round is a Series A, in Jan 2024.
Where is OnCusp Therapeutics based?
OnCusp Therapeutics is based in the United States.
Companies like OnCusp Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.